top of page

86% nocturia reduction in Direct-to-Bladder clinical trial.

This research by Dr Luna-Rivera is one of many pieces of evidence that Direct-to-Bladder therapies can produce better outcomes than taking the drug orally.

The most notable parts in this article are:

  • Nocturia (passing urine in the night) decreased after 10 doses of bladder instillation.

  • Urinary urgency reduced by 86%.

  • Oral antimuscarinics are the first line of treatment but not always effective, …and have been associated with adverse effects that limit their use.

  • This clinical trial show almost no presence of undesirable side effects, in addition to a notable improvement in quality-of-life.


Luna Rivera et al
.pdf
Download PDF • 353KB

We’ll be very interested in your feedback and questions


34 views0 comments

Recent Posts

See All

Doctors with commercial interests.

I offer this “case report” and cautionary note to dedicated doctors with inventive minds. For many years in UK medicine, the most publicly trusted profession, I investigated intravesical treatments, i

OAB tablets and patient safety

#Overactivebladder syndrome, (OAB), describing #urinaryurgency of unknown cause, was so named because #urodynamic investigations of complainants revealed #bladdercontractions at volumes below expected

Comments


bottom of page